RESUMO
Delirium, (acute confusional episode in European nomenclature) frequently occurs to elderly patients. This confusional condition is characterized by a sudden beginning and fluctuating clinical manifestations. It can bring out or showup a large number of illnesses. Generally transient and reversible, confusional state remains a medical emergency, motivating numerous consilium and psychiatric admissions. On the base of a case report, we aim to recall the high frequency of this affection in a somatic context and the importance of early diagnosis and treatment.
Assuntos
Confusão/classificação , Delírio/classificação , Idoso , Confusão/epidemiologia , Confusão/terapia , Delírio/epidemiologia , Delírio/terapia , Humanos , IncidênciaRESUMO
In every day practice, it is difficult, sometimes impossible, and always ethically delicate to determine the differential diagnosis between: disorders of a somatic nature, simulation and factitious disorders, as much for the psychiatrist as for the general practitioner in the front line. Our aim is to lead a reflection on this controversial theme on the basis of a clinical illustration.
Assuntos
Transtornos Autoinduzidos/diagnóstico , Transtornos Somatoformes/diagnóstico , Transtornos de Estresse Pós-Traumáticos/diagnóstico , Adulto , Diagnóstico Diferencial , Transtornos Autoinduzidos/terapia , Feminino , Humanos , Síndrome de Munchausen/diagnóstico , Transtornos Somatoformes/terapia , Transtornos de Estresse Pós-Traumáticos/terapia , Resultado do TratamentoRESUMO
Our clinic has fortuitously developed the therapeutic use of the association of mianserin (maximum daily dose 90 mg) and carbamazepine (maximum daily dose 400 mg) in opiate withdrawal management. If animal studies have suggested efficacy of mianserin in such indication, no human studies have been performed. To test the efficacy of such an association, a comparison was made to clonidine (maximum daily dose 0.600 mg) in a one week treatment period according to a double blind pilot study design. Thirty-two patients were included (16 in each treatment group). The two treatments did not differ in the intensity of the withdrawal, according to the rate of retention in treatment and symptoms, and the psychic distress which were auto-evaluated every other day with the Opiate Withdrawal Questionnaire and several Visual Analog Scales (VAS). The clonidine group, however, scored significantly higher (P < 0.05) on the VAS rating of the global feeling of satisfaction on the last day. The patients in the mianserin group fortuitously had a moderately lower number of daily heroin intakes but there was no significant correlation between this variable and the global OWQ scores on Days 1, 3, 5 and 7. Given the size of the groups, we cannot conclude that the association carbamazepine-mianserin is as effective as clonidine, but a real effectiveness is probable. A study versus placebo would be necessary to draw more definitive conclusions.